Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?

• Format: eBook
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Subjects: Medicine and Nursing; adverse events; aged; bladder inflammation; bladder oversensitivity; bladder pain syndrome; bladder pain syndrome/interstitial cystitis; botox; botulinum toxin; botulinum toxin A; botulinum toxin A injection; botulinum toxins; detrusor overactivity; detrusor underactivity; dysfunctional voiding; dyssynergia; incontinence; interstitial cystitis; interstitial cystitis/bladder pain syndrome; intravesical injection; liposome; long-term treatment; lower urinary tract symptoms; lower-urinary-tract dysfunction; men; n/a; neurogenic bladder; onabotulinum toxin A; onabotulinumtoxinA; overactive; overactive bladder; Parkinson's disease; platelet-rich plasma; poor relaxation of the external sphincter; postoperative complications; Sapylin; spinal cord injury; stroke; therapeutic efficacy; type A; urethral; urethral sphincter dysfunction; urinary bladder; urinary incontinence; urine biomarkers; voiding dysfunction
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication

 Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Special Issue has collected original or review articles that focus on the novel applications of botulinum toxin A in LUTDs. The research has been updated and contains novel therapeutic applications of botulinum toxin for bladder or urethral dysfunctions. This Special Issue of Toxins provides current knowledge surrounding the status of botulinum toxin in functional urology and LUTDs.